Related Experiment Video

Updated: Aug 18, 2026

Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness

Published on: May 3, 2018

[Treatment decision as a function of cardiovascular risk in isolated systolic hypertension in general medicine. The

T Denolle1, H Gallois, P L'Hostis

  • 1Unité HTA, centre de prévention cardiovasculaire, hôpital La Providence Gardiner, 35800 Dinard.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|October 9, 2002
PubMed

Insights

General practitioners consider patient risk factors when deciding on isolated systolic hypertension (ISH) treatment. While most decisions align with guidelines, some patients with low or high cardiovascular risk were undertreated or overtreated.

Area of Science:

  • Cardiology
  • General Practice
  • Public Health

Context:

  • Isolated systolic hypertension (ISH) affects a significant patient population.
  • General practitioners (GPs) manage ISH, influencing cardiovascular disease (CVD) risk.
  • Understanding treatment decisions in ISH is crucial for effective hypertension management.

Purpose:

  • To analyze the treatment decisions made by GPs for patients with isolated systolic hypertension (ISH).
  • To identify patient characteristics influencing GP treatment choices in ISH.
  • To evaluate adherence to ISH treatment recommendations.

Summary:

  • A study of 11,436 patients with ISH (SBP ≥ 140, DBP < 90 mmHg) examined GP treatment decisions.
  • GPs considered ISH grade, risk factors, and cardiovascular risk levels, aligning with recommendations in 91% of cases.
  • However, discrepancies were noted, with undertreatment in low-risk and overtreatment in high-risk patients.

Impact:

  • Findings highlight the importance of considering multiple factors in ISH treatment decisions.
  • Reveals potential gaps in adhering to ISH guidelines, particularly for low and high-risk individuals.
  • Informs strategies for optimizing hypertension management and reducing cardiovascular events.
Abstract

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...